Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1962;25:281-291

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by GILLESPIE, L.
Right arrow Articles by SJOERDSMA, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by GILLESPIE, L., JR.
Right arrow Articles by SJOERDSMA, A.

(Circulation. 1962;25:281.)
© 1962 American Heart Association, Inc.


Clinical and Chemical Studies with agr-Methyl-Dopa in Patients with Hypertension

LOUIS GILLESPIE JR. M.D.; JOHN A. OATES M.D.; J. RICHARD CROUT M.D.; ALBERT SJOERDSMA M.D., PH.D.

A series of observations in 52 hypertensive patients is presented indicating that agr-methyl-dopa is an effective antihypertensive agent.

The antihypertensive properties of the agent were discovered in the course of biochemical studies with the racemic compound the form used in initial therapeutic trials.

Studies on metabolism of dl-agr-methyl-dopa indicate incomplete intestinal absorption and rapid excretion in the urine as unchanged drug and as agr-methyl-dopamine. The former finding does not seem to be a significant deterrent to its use orally.

Comparisons of the d and l isomers of agr-methyl-dopa in hypertensive patients showed that all the chemical and pharmacologic effects reside in the l-isomer (Aldomet). Thus, recent studies have been performed with Aldomet exclusively.

From observations to date the impression has been gained that Aldomet has several advantages over other antihypertensive agents; these include effectiveness against all degrees of hypertension, frequent lowering of recumbent as well as standing blood pressure, smoothness of effect, and tranquilizing effects. Questions of toxicity and tolerance are not yet completely answered.

Sympathetic blockade at a central or peripheral site is the probable basis of the drug's action. This effect may be unrelated to the biochemical property of inhibiting the decarboxylation of aromatic l-amino acids and is possibly due to depletion of tissue stores of norepinephrine by a mechanism not yet fully defined.